MedPage Today February 10, 2023
— Drugmakers who hike prices too fast must repay Medicare
WASHINGTON — The Biden administration issued initial guidance yesterday on how it plans to implement the Medicare drug rebate program, which will affect doctors who administer drugs under Medicare Part B.
The program, passed in August 2022 as part of the Inflation Reduction Act, requires manufacturers who raise their drugs’ prices faster than the rate of inflation to pay rebates to the federal government. The rebate rule, which applies to drugs administered to beneficiaries under either the Medicare Part B or Medicare Part D program, requires the companies to pay the rebates directly to the Medicare trust fund.
Medicare beneficiaries whose prescription drugs are subject to a rebate “will also...
Today's Sponsors
Today's Sponsor